日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054

更正:拮抗剂抗PD-L1单克隆抗体LY3300054的发现和临床前表征

Li, Yiwen; Carpenito, Carmine; Wang, George; Surguladze, David; Forest, Amelie; Malabunga, Maria; Murphy, Mary; Zhang, Yiwei; Sonyi, Andreas; Chin, Darin; Burtrum, Douglas; Inigo, Ivan; Pennello, Anthony; Shen, Leyi; Malherbe, Laurent; Chen, Xinlei; Hall, Gerald; Haidar, Jaafar N; Ludwig, Dale L; Novosiadly, Ruslan D; Kalos, Michael

Pleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma models.

血管内皮生长因子受体 2 抗体疗法在肾细胞癌模型中的多效性基质效应

Duignan Inga J, Corcoran Erik, Pennello Anthony, Plym Mary Jane, Amatulli Michael, Claros Nidia, Iacolina Michelle, Youssoufian Hagop, Witte Larry, Samakoglu Selda, Schwartz Jonathan, Surguladze David, Tonra James R